CANEPHRON cpr 30 pce

7680674190011 CH-67419 G04BX 05.02.0.
CANEPHRON cpr 30 pce
CANEPHRON cpr 30 pce
CANEPHRON cpr 30 pce
1 / 3
google

Details

Product number
6741901
CPT
-
Packaging group
30
Unit
Dragée(s)
Composition
centaurii herbae pulvis (Centaurium erythraea Rafn s.l., herba) 36 mg, levistici radicis pulvis (Levisticum officinale Koch, radix) 36 mg, rosmarini folii pulvis (Rosmarinus officinalis L., folium) 36 mg, lactosum monohydricum 90 mg, magnesii stearas, maydis amylum, povidonum K 25, silica colloidalis anhydrica, Überzug: calcii carbonas, ricini oleum virginale, glucosum liquidum dispersione desiccatum 2.172 mg, E 172 (rubrum), maydis amylum, dextrinum, cera montanglycoli, povidonum K 30, E 101, lacca, saccharum 120.862 mg, talcum, E 171, pro compresso obducto.

Articles (1)

Canephron, überzogene Tabletten
überzogene Tabletten
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
12/03/2021
Patient information leaflet
Français
12/03/2021
Patient information leaflet
Italien
12/03/2021
Professional SmPC
Allemand
12/03/2021
Professional SmPC
Français
12/03/2021
Professional SmPC
Italien
12/03/2021

Detailed composition

Substance Quantity Type Category
(N/A)
36.0 MG Substance Wirkstoff (Principe actif)
(N/A)
36.0 MG Substance Wirkstoff (Principe actif)
(N/A)
36.0 MG Substance Wirkstoff (Principe actif)
(N/A)
90.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
2.172 MG Substance HBESI
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
120.862 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK

Authorization holder

Biomed AG

8600 Dübendorf

Authorization information

Swissmedic authorization number
67419
Drug name
Canephron, überzogene Tabletten
Galenic form
UEBT
ATC Code
G04BX
Authorization status
Z
Dispensation category
D
First authorization
01/10/2020
Authorization expiration date
31/12/9999
IT number
05.02.0.
Domain
Human medicine
Field of application
Traditionsgemäss als unterstützende Behandlung bei unkomplizierten Harnwegsinfekten der Frau und zur Durchspülung der Harnwege

Packaging details

Description (FR)
CANEPHRON cpr 30 pce
Description (DE)
CANEPHRON Tabl 30 Stk
Market launch
01/10/2020
Narcotic (BTM)
No